Factorial Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-500
Closed -$9.05K 101
2020
Q2
$9.05K Hold
500
0.01% 95
2020
Q1
$7.2K Sell
500
-500
-50% -$14.4K 0.01% 103
2019
Q4
$38K Sell
1,000
-2,500
-71% -$74.9K 0.03% 96
2019
Q3
$77.4K Sell
3,500
-13,500
-79% -$288K 0.07% 103
2019
Q2
$351K Sell
17,000
-28,400
-63% -$655K 0.34% 87
2019
Q1
$1.31M Sell
45,400
-6,000
-12% -$148K 1.23% 25
2018
Q4
$881K Buy
51,400
+7,000
+16% +$169K 0.92% 33
2018
Q3
$1.26M Buy
44,400
+500
+1% +$16.5K 1.09% 33
2018
Q2
$1.47M Sell
43,900
-3,200
-7% -$99.5K 1.32% 26
2018
Q1
$1.14M Buy
47,100
+12,000
+34% +$239K 1.04% 31
2017
Q4
$532K Buy
+35,100
New +$494K 0.49% 67

Other funds holding THC

Factorial Partners's THC Position: Q3 2020 in Review

Factorial Partners sold out of Tenet Healthcare (THC) in Q3 2020, closing a stake of 500 shares — an estimated $9.05K sold.

Factorial Partners first reported a position in THC in Q4 2017 and held it in 11 quarters. The position peaked at $1.47M in Q2 2018. 245 funds tracked by Wall St. Rank hold THC as of Q3 2020.

  • Factorial Partners reported no remaining Tenet Healthcare position as of Q3 2020 after selling out during the quarter.
  • Factorial Partners sold 500 Tenet Healthcare shares in Q3 2020, an estimated $9.05K.
  • Factorial Partners first reported a position in Tenet Healthcare in Q4 2017 and held it in 11 quarters.
  • Factorial Partners's Tenet Healthcare position peaked at $1.47M in Q2 2018.
  • 245 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2020.

Based on Factorial Partners's 13F filing for Q3 2020, filed 12 Nov 2020.